Skip to main content

Articles

Page 14 of 18

  1. In resource limited settings non-availability of CD4 count facility at the site could adversely affect the ART roll out programme. Point of care CD4 enumerating equipments can make the CD4 count available at t...

    Authors: Madhuri Thakar, Bharati Mahajan, Nawaj Shaikh, Salman Bagwan, Suvarna Sane, Sandhya Kabra, Bharat Rewari, Mohamad Shaukat, Namita Singh, Peter Trevor and Ramesh Paranjape
    Citation: AIDS Research and Therapy 2012 9:26
  2. The true prevalence of HIV and other sexually transmitted diseases among street children in Nepal is virtually unknown while information on related behavioural risk factors in this population is non-existent. ...

    Authors: Dibesh Karmacharya, Dongmei Yu, Sameer Dixit, Rajesh Rajbhandari, Bhawana Subedi, Sonu Shrestha, Sulochana Manandhar and Susan L Santangelo
    Citation: AIDS Research and Therapy 2012 9:25
  3. This study reports the clinical characteristics and outcome of HIV-associated Penicilliummarneffei infection in northern Vietnam.

    Authors: Mattias Larsson, Lien Ha Thi Nguyen, Heiman FL Wertheim, Trinh Tuyet Dao, Walter Taylor, Peter Horby, Trung Vu Nguyen, Minh Ha Thi Nguyen, Thuy Le and Kinh Van Nguyen
    Citation: AIDS Research and Therapy 2012 9:24
  4. The 2012 International Symposium on HIV and Emerging Infectious Diseases (ISHEID) provided a forum for investigators to hear the latest research developments in the clinical management of HIV and HCV infection...

    Authors: Alain Lafeuillade, Vicente Soriano, Marie Suzan-Monti, Mario Stevenson, Jacques Izopet and Hans-Jürgen Stellbrink
    Citation: AIDS Research and Therapy 2012 9:23
  5. CCR5 antagonists have clinically been approved for prevention or treatment of HIV/AIDS. Countries in Sub-Saharan Africa with the highest burden of HIV/AIDS are due to adopt these regimens. However, HIV-1 can a...

    Authors: Veronica Wambui, Michael Kiptoo, Joyceline Kinyua, Irene Odera, Edward Muge, Peter Muiruri, Raphael Lihana, Peter Kinyanjui and Elijah M Songok
    Citation: AIDS Research and Therapy 2012 9:22
  6. The high cost of CD4 count estimation in resource-limited countries is a major challenge in initiating patients on highly active antiretroviral therapy (HAART). Therefore, assessment of inexpensive and simple ...

    Authors: Yitayih Wondimeneh, Getachew Ferede, Gizachew Yismaw and Dagnachew Muluye
    Citation: AIDS Research and Therapy 2012 9:21

    The Erratum to this article has been published in AIDS Research and Therapy 2013 10:2

  7. Limited data exist for the efficacy of second-line antiretroviral therapy among children in resource limited settings. We assessed the virologic response to protease inhibitor-based ART after failing first-lin...

    Authors: Thanyawee Puthanakit, Gonzague Jourdain, Piyarat Suntarattiwong, Kulkanya Chokephaibulkit, Umaporn Siangphoe, Tulathip Suwanlerk, Wasana Prasitsuebsai, Virat Sirisanthana, Pope Kosalaraksa, Witaya Petdachai, Rawiwan Hansudewechakul, Naris Waranawat and Jintanat Ananworanich
    Citation: AIDS Research and Therapy 2012 9:20
  8. The aim of this study was to explore the effects of HCV co-infection on virological effectiveness and on CD4+ T-cell recovery in patients with an early and sustained virological response after HAART.

    Authors: Davide Motta, Nigritella Brianese, Emanuele Focà, Paola Nasta, Franco Maggiolo, Massimiliano Fabbiani, Giuliana Cologni, Simona Di Giambenedetto, Massimo Di Pietro, Nicoletta Ladisa, Laura Sighinolfi, Silvia Costarelli, Filippo Castelnuovo and Carlo Torti
    Citation: AIDS Research and Therapy 2012 9:18
  9. Tuberculosis (TB) is the most common co infection in HIV-infected persons in India, requiring concomitant administration of anti TB and antiretroviral therapies. Paradoxical worsening of tuberculosis after ant...

    Authors: Upasna Agarwal, Amitabh Kumar, Digamber Behera, Martyn A French and Patricia Price
    Citation: AIDS Research and Therapy 2012 9:17
  10. Studies indicate that there is high early mortality among patients starting antiretroviral treatment in sub-Saharan Africa. However, there is paucity of evidence on long term survival of patients on anti-retro...

    Authors: Sibhatu Biadgilign, Ayalu A Reda and Tesfaye Digaffe
    Citation: AIDS Research and Therapy 2012 9:15
  11. To identify the determinants of successful antiretroviral (ARV) therapy, researchers study the virological responses to treatment-change episodes (TCEs) accompanied by baseline plasma HIV-1 RNA levels, CD4+ T ...

    Authors: Soo-Yon Rhee, Jose Luis Blanco, Tommy F Liu, Iñaki Pere, Rolf Kaiser, Maurizio Zazzi, Francesca Incardona, William Towner, Josep Maria Gatell, Andrea De Luca, W Jeffrey Fessel and Robert W Shafer
    Citation: AIDS Research and Therapy 2012 9:13
  12. This case report describes an HIV-positive patient with recurrent tuberculosis in Uganda. After several failed courses of treatment, the patient was diagnosed with multi-drug resistant tuberculosis (MDR-TB). A...

    Authors: Emmanuel Luyirika, Henry Nsobya, Richard Batamwita, Pheona Busingye, William Musoke, Lillian Nabiddo, Yvonne Karamagi and Barbara Mukasa
    Citation: AIDS Research and Therapy 2012 9:12
  13. Even though the prevalence of HIV infection among the adult population in Ethiopia was estimated to be 2.2% in 2008, the studies on the pattern of neurological manifestations are rare. The aim of this retrospe...

    Authors: Tesfaye Berhe, Yilma Melkamu and Amanuel Amare
    Citation: AIDS Research and Therapy 2012 9:11
  14. Delayed-type hypersensitivity (DTH) testing, an in vivo assessment of cell-mediated immunity, is a predictor of HIV disease progression beyond CD4 cell count. We investigated whether preserved DTH responsivene...

    Authors: Jason F Okulicz, Greg A Grandits, Matthew J Dolan, Vincent C Marconi, Glenn Wortmann and Michael L Landrum
    Citation: AIDS Research and Therapy 2012 9:10
  15. HIV spread continues at high rates from infected persons to their sexual partners. In 2009, an estimated 2.6 million new infections occurred globally. People living with HIV (PLHIV) receiving treatment are in ...

    Authors: Avina Sarna, Stanley Luchters, Melissa Pickett, Matthew Chersich, Jerry Okal, Scott Geibel, Nzioki Kingola and Marleen Temmerman
    Citation: AIDS Research and Therapy 2012 9:9
  16. We continue the previously described prospective cohort study of ritonovir-boosted lopinavir (LPV/r) monotherapy for second-line therapy in HIV-infected patients with prior failure and extensive resistance to ...

    Authors: Weerawat Manosuthi, Supeda Thongyen, Samruay Nilkamhang, Sukanya Manosuthi and Somnuek Sungkanuparph
    Citation: AIDS Research and Therapy 2012 9:8
  17. The December 2011 5th International Workshop on HIV Persistence during Therapy addressed the issue of HIV persistence among 210 scientists from 10 countries involved in the study of HIV reservoirs and the search ...

    Authors: Mario Stevenson, Nicolas Chomont and Alain Lafeuillade
    Citation: AIDS Research and Therapy 2012 9:7
  18. Hepatic Flare (HF) after initiation of highly active antiretroviral therapy (HAART) in HIV-HBV coinfected individuals is well recognized but prospective data on predictors and subsequent outcome are limited.

    Authors: Anchalee Avihingsanon, Gail V Matthews, Sharon R Lewin, Pip Marks, Jose Sasadeusz, David A Cooper, Scott Bowden, Stephen Locarnini, Greg J Dore and Kiat Ruxrungtham
    Citation: AIDS Research and Therapy 2012 9:6
  19. Little is known about HIV-1 subtype distribution in Morocco. Some data suggest an emergence of new HIV subtypes. We conducted phylogenetic analysis on a nationally representative sample of 60 HIV-1 viral speci...

    Authors: Mohammed Akrim, Sanae Lemrabet, Elmir Elharti, Rebecca R Gray, Jean Claude Tardy, Robert L Cook, Marco Salemi, Patrice Andre, Taj Azarian and Rajae El Aouad
    Citation: AIDS Research and Therapy 2012 9:5
  20. Although highly active antiretroviral therapy (HAART) has improved HIV survival, some patients receiving therapy are still dying. This analysis was conducted to identify factors associated with increased risk ...

    Authors: Alan R Lifson, Elizabeth M Krantz, Patricia L Grambsch, Grace E Macalino, Nancy F Crum-Cianflone, Anuradha Ganesan, Jason F Okulicz, Anne Eaton, John H Powers, Lynn E Eberly and Brian K Agan
    Citation: AIDS Research and Therapy 2012 9:4
  21. Several lines of evidence suggest that retinoids (retinol-ROL or vitamin A, and its active metabolites, retinoic acids-RAs) play important pathogenic roles in HIV infection and combination antiretroviral thera...

    Authors: Maude Loignon, Hélène Brodeur, Sonia Deschênes, Denis Phaneuf, Pangala V Bhat and Emil Toma
    Citation: AIDS Research and Therapy 2012 9:3
  22. Recently, it has been shown that human ejaculate enhances human immunodeficiency virus 1 (HIV-1) infectivity. Enhancement of infectivity is conceived to be mediated by amyloid filaments from peptides that are ...

    Authors: Philip Hartjen, Sebastian Frerk, Ilona Hauber, Verena Matzat, Adriana Thomssen, Barbara Holstermann, Heinrich Hohenberg, Wolfgang Schulze, Julian Schulze zur Wiesch and Jan van Lunzen
    Citation: AIDS Research and Therapy 2012 9:2
  23. Use of dietary supplements is common among people living with HIV/AIDS. Because dietary supplements are used in the context of other health behaviors, they may have direct and indirect health benefits. However...

    Authors: Seth C Kalichman, Chauncey Cherry, Denise White, Miche'l Jones, Moira O Kalichman, Mervi A Detorio, Angela M Caliendo and Raymond F Schinazi
    Citation: AIDS Research and Therapy 2012 9:1
  24. Behaviour change which is highly influenced by risk perception is a major challenge that HIV prevention efforts need to confront. In this study, we examined the validity of self-reported likelihood of HIV infe...

    Authors: Adeniyi F Fagbamigbe, Joshua O Akinyemi, Babatunde O Adedokun and Elijah A Bamgboye
    Citation: AIDS Research and Therapy 2011 8:44
  25. Antiretroviral therapy (ART) requires high-level (> 95%) adherence. Kenya is rolling out ART access programmes and, issue of adherence to therapy is therefore imperative. However, published data on adherence t...

    Authors: Samwel N Wakibi, Zipporah W Ng'ang'a and Gabriel G Mbugua
    Citation: AIDS Research and Therapy 2011 8:43
  26. The use of combination antiretroviral therapy (cART) has become a standard of care for the treatment of HIV infection. However, cost and resistance to cART are major obstacles for access to treatment especiall...

    Authors: Nitta Khienprasit, Romanee Chaiwarith, Thira Sirisanthana and Khuanchai Supparatpinyo
    Citation: AIDS Research and Therapy 2011 8:42
  27. Rifampicin reduces the plasma concentrations of nevirapine in human immunodeficiency virus (HIV) and tuberculosis (TB) co-infected patients, who are administered these drugs concomitantly. We conducted a prosp...

    Authors: Sanjeev Sinha, Sahajal Dhooria, Sanjiv Kumar, Nipam Shah, T Velpandian, AK Ravi, Narendra Kumar, Hafeez Ahmad, Akshat Bhargwa, Karan Chug, Naresh Bumma, Rahul Chandrashekhar, Meera Ekka, Vishnu Sreenivas, Surendra K Sharma, JC Samantaray…
    Citation: AIDS Research and Therapy 2011 8:41
  28. There are limited data of immunologic and virologic failure in Asian HIV-infected children using non-nucleoside reverse transcriptase inhibitor (NNRTI)-based highly active antiretroviral therapy (HAART). We ex...

    Authors: Torsak Bunupuradah, Thanyawee Puthanakit, Pope Kosalaraksa, Stephen Kerr, Pitch Boonrak, Wasana Prasitsuebsai, Pagakrong Lumbiganon, Tawan Mengthaisong, Chayapa Phasomsap, Chitsanu Pancharoen, Kiat Ruxrungtham and Jintanat Ananworanich
    Citation: AIDS Research and Therapy 2011 8:40
  29. There have been few reports of long-term survival of HIV-infected patients on antiretroviral therapy (ART) in Africa managed under near normal health service conditions.

    Authors: Barbara Amuron, Jonathan Levin, Josephine Birunghi, Geoffrey Namara, Alex Coutinho, Heiner Grosskurth and Shabbar Jaffar
    Citation: AIDS Research and Therapy 2011 8:39
  30. Drug resistance testing before initiation of, or during, antiretroviral therapy (ART) is not routinely performed in resource-limited settings. High levels of viral resistance circulating within the population ...

    Authors: Vijay B Bansode, Simon AA Travers, Amelia C Crampin, Bagrey Ngwira, Neil French, Judith R Glynn and Grace P McCormack
    Citation: AIDS Research and Therapy 2011 8:38
  31. Partners In Health (PIH) works with the Ministry of Health to provide comprehensive health services in Haiti. Between 1994 and 2009, PIH recommended exclusive formula feeding in the prevention of mother-to-chi...

    Authors: Louise C Ivers, Sasha C Appleton, Bingxia Wang, J Gregory Jerome, Kimberly A Cullen and Mary C Smith Fawzi
    Citation: AIDS Research and Therapy 2011 8:37
  32. Highly effective antiviral treatment can suppress HIV-1 infection, but the chronic effects of HIV-1-related viral proteins, including gp120 and Tat, on organs such as the lungs can be damaging. HIV-1 transgeni...

    Authors: Pratibha C Joshi and David M Guidot
    Citation: AIDS Research and Therapy 2011 8:36
  33. CD4+ T lymphocyte counts are the most important indicator of disease progression and success of antiretroviral treatment in HIV infection in resource limited settings. The nationwide reference range of CD4+ T ...

    Authors: Madhuri R Thakar, Philip R Abraham, Sunil Arora, Pachamuthu Balakrishnan, Bhaswati Bandyopadhyay, Ameeta A Joshi, K Rekha Devi, Ravi Vasanthapuram, Madhu Vajpayee, Anita Desai, Janardhanan Mohanakrishnan, Kanwar Narain, Krishnangshu Ray, Shilpa S Patil, Ravinder Singh, Anuj Singla…
    Citation: AIDS Research and Therapy 2011 8:35
  34. We report an unusual case of HIV-related immune reconstitution inflammatory syndrome, presenting as suspected AIDS-related lymphoma. Symptoms, initial investigations including fine-needle biopsy and 18F-FDG PE...

    Authors: Bo K Mortensen, Susanne D Nielsen, Charlotte B Christensen and Jannik Helweg-Larsen
    Citation: AIDS Research and Therapy 2011 8:34
  35. Data on lipid profile derangements induced by antiretroviral treatment in Africa are scarce. The aim of this study was to determine the prevalence and characteristics of lipid profile derangements associated w...

    Authors: Eric Walter Pefura Yone, Awa Foueudjeu Betyoumin, André Pascal Kengne, François Jérome Kaze Folefack and Jeanne Ngogang
    Citation: AIDS Research and Therapy 2011 8:33
  36. Effective interventions to prevent mother-to-child HIV transmission (PMTCT) exist and when properly applied reduce the risk of vertical HIV transmission. As part of optimizing PMTCT in the Dutch Caribbean we d...

    Authors: Hillegonda S Hermanides, Lonneke A van Vught, Ralph Voigt, Fred D Muskiet, Aimée Durand, Gerard van Osch, Sharline Koolman-Wever, Isaac Gerstenbluth, Colette Smit and Ashley J Duits
    Citation: AIDS Research and Therapy 2011 8:32
  37. We examined trends in AIDS-defining illnesses (ADIs) among individuals receiving highly active antiretroviral therapy (HAART) in British Columbia (BC), Canada to determine whether declines in ADIs could be con...

    Authors: Siavash Jafari, Keith Chan, Kewan Aboulhosn, Benita Yip, Viviane D Lima, Robert S Hogg, Julio Montaner and David M Moore
    Citation: AIDS Research and Therapy 2011 8:31
  38. Separately, chronic alcohol ingestion and HIV-1 infection are associated with severe skeletal muscle derangements, including atrophy and wasting, weakness, and fatigue. One prospective cohort study reported th...

    Authors: Caroline R Clary, Daniel M Guidot, Margaux A Bratina and Jeffrey S Otis
    Citation: AIDS Research and Therapy 2011 8:30
  39. We aimed to determine the reliability and validity of a hepatitis symptom inventory and to identify predictors of hepatitis C (HCV) treatment initiation in a cohort of HIV-infected patients.

    Authors: Edward R Cachay, David L Wyles, Miguel Goicoechea, Francesca J Torriani, Craig Ballard, Bradford Colwell, Robert G Gish and William C Mathews
    Citation: AIDS Research and Therapy 2011 8:29
  40. Highly Active Antiretroviral Therapy (HAART) has been available free of charge in Tanga, Tanzania since 2005. However we have found that a high percentage of women referred from prevention of mother-to-child t...

    Authors: Zahra P Theilgaard, Terese L Katzenstein, Mercy G Chiduo, Christiane Pahl, Ib C Bygbjerg, Jan Gerstoft, Martha M Lemnge and Britt P Tersbøl
    Citation: AIDS Research and Therapy 2011 8:28
  41. RC-101, a cationic peptide retrocyclin analog, has in vitro activity against HIV-1. Peptide drugs are commonly prone to conformational changes, oxidation and hydrolysis when exposed to excipients in a formulation...

    Authors: Alexandra B Sassi, Katherine E Bunge, Brian L Hood, Thomas P Conrads, Alexander M Cole, Phalguni Gupta and Lisa C Rohan
    Citation: AIDS Research and Therapy 2011 8:27
  42. Genotype-derived drug resistance profiles are a valuable asset in HIV-1 therapy decisions. Therapy decisions could be further improved, both in terms of predicting length of current therapy success and in pres...

    Authors: Glenn Lawyer, André Altmann, Alexander Thielen, Maurizio Zazzi, Anders Sönnerborg and Thomas Lengauer
    Citation: AIDS Research and Therapy 2011 8:26
  43. The aim of this study was to describe the extent of the HIV epidemic among women in the Republic of Georgia and to identify factors associated with HCV co-infection in this population.

    Authors: Nikoloz Chkhartishvili, Louise-Anne McNutt, Perry F Smith and Tengiz Tsertsvadze
    Citation: AIDS Research and Therapy 2011 8:25
  44. High early mortality rate among HIV infected patients following initiation of antiretroviral therapy (ART) in resource limited settings may indicate high pre-treatment mortality among ART-eligible patients. Th...

    Authors: Toyin Togun, Ingrid Peterson, Shabbar Jaffar, Francis Oko, Uduak Okomo, Kevin Peterson and Assan Jaye
    Citation: AIDS Research and Therapy 2011 8:24
  45. HAART has significantly reduced AIDS-related morbidity in children. However, limited evidence is available from developing countries regarding patterns of opportunistic illnesses. We describe these events and ...

    Authors: Alberto N Ramos Jr, Luiza H Matida, Norman Hearst and Jorg Heukelbach
    Citation: AIDS Research and Therapy 2011 8:23
  46. Early diagnosis of HIV infection can prevent morbidity and mortality as well as reduce HIV transmission. The aim of the present study was to assess prevalence, describe trends and identify factors associated w...

    Authors: Patricia Garcia de Olalla, Christian Manzardo, Maria A Sambeat, Inma Ocaña, Hernando Knobel, Victoria Humet, Pere Domingo, Esteve Ribera, Ana Guelar, Andres Marco, Maria J Belza, Josep M Miró and Joan A Caylà
    Citation: AIDS Research and Therapy 2011 8:22
  47. High dosage of intravenous immunoglobulin (IVIG) has been observed as a possible activator of HIV gene expression in latently infected resting CD4+ T-cells, leading to a substantial decrease in both the reservoir...

    Authors: Tomas Mellberg, Veronica D Gonzalez, Annica Lindkvist, Arvid Edén, Anders Sönnerborg, Johan K Sandberg, Bo Svennerholm and Magnus Gisslén
    Citation: AIDS Research and Therapy 2011 8:21